|
EP4793360A2
(en)
|
2006-03-31 |
2026-08-19 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for controlling blood pharmacokinetics of antibodies
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
EP3127921A1
(en)
|
2007-09-26 |
2017-02-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method of modifying isoelectric point of antibody via amino acid substition in cdr
|
|
TW201920257A
(zh)
|
2008-04-11 |
2019-06-01 |
日商中外製藥股份有限公司 |
重複結合複數個抗原的抗原結合分子
|
|
KR102049223B1
(ko)
|
2010-11-04 |
2019-11-28 |
베링거 인겔하임 인터내셔날 게엠베하 |
항－ｉｌ－２３ 항체
|
|
TWI654203B
(zh)
|
2010-11-30 |
2019-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
具有鈣依存性的抗原結合能力之抗體
|
|
CA2840270C
(en)
*
|
2011-06-22 |
2023-09-26 |
Apellis Pharmaceuticals, Inc. |
Methods of treating chronic disorders with complement inhibitors
|
|
WO2013006810A1
(en)
|
2011-07-06 |
2013-01-10 |
Nestec Sa |
Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha
|
|
EP2583979B1
(en)
|
2011-10-19 |
2015-12-16 |
Effimune |
Methods to prepare antibodies directed against p19 subunit of human IL-23
|
|
CA2865158C
(en)
|
2012-02-24 |
2022-11-01 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule for promoting disappearance of antigen via fc.gamma.riib
|
|
CN109206516A
(zh)
|
2012-05-03 |
2019-01-15 |
勃林格殷格翰国际有限公司 |
抗IL-23p19抗体
|
|
US9738724B2
(en)
*
|
2012-06-08 |
2017-08-22 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP3135690A1
(en)
|
2012-06-26 |
2017-03-01 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
TWI855488B
(zh)
|
2012-08-24 |
2024-09-11 |
日商中外製藥股份有限公司 |
FcγRIIb特異性Fc區域變異體
|
|
JP6774164B2
(ja)
|
2012-08-24 |
2020-10-21 |
中外製薬株式会社 |
マウスＦｃγＲＩＩ特異的Ｆｃ抗体
|
|
SI2890402T1
(sl)
|
2012-08-31 |
2019-07-31 |
Sutro Biopharma, Inc. |
Modificirane aminokisline vsebujoče acido skupino
|
|
US9670521B2
(en)
|
2012-09-24 |
2017-06-06 |
Medimmune Limited |
Amino acid derivatives
|
|
US10131920B2
(en)
|
2013-03-15 |
2018-11-20 |
Medimmune Limited |
Nucleic acid molecules
|
|
SG11201508170TA
(en)
|
2013-04-02 |
2015-11-27 |
Chugai Pharmaceutical Co Ltd |
Fc REGION VARIANT
|
|
WO2015006555A2
(en)
*
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
CN105980350B
(zh)
|
2013-08-05 |
2018-11-27 |
米迪缪尼有限公司 |
氨基酸衍生物
|
|
KR102460736B1
(ko)
|
2014-05-10 |
2022-10-31 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
화학적으로-로킹된 이중특이적 항체
|
|
EP3172339A1
(en)
|
2014-07-24 |
2017-05-31 |
Boehringer Ingelheim International GmbH |
Biomarkers useful in the treatment of il-23a related diseases
|
|
CA2959629C
(en)
|
2014-09-03 |
2023-10-31 |
Boehringer Ingelheim International Gmbh |
Compound targeting il-23a and tnf-alpha and uses thereof
|
|
RU2017122720A
(ru)
*
|
2014-12-05 |
2019-01-10 |
Нестек С.А. |
Непрямые однородные анализы по изменению подвижности для детекции биологических препаратов в образцах пациента
|
|
MX2017005774A
(es)
|
2014-12-19 |
2017-07-28 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
|
|
KR20170120616A
(ko)
|
2015-02-04 |
2017-10-31 |
베링거 인겔하임 인터내셔날 게엠베하 |
염증성 질환의 치료 방법
|
|
CN114773469B
(zh)
|
2015-02-05 |
2025-12-19 |
中外制药株式会社 |
包含离子浓度依赖性的抗原结合结构域的抗体，fc区变体，il-8-结合抗体及其应用
|
|
US10709839B2
(en)
|
2015-03-04 |
2020-07-14 |
Repro-Med Systems, Inc. |
Precision variable flow rate infusion system and method
|
|
JP6967221B2
(ja)
|
2015-08-19 |
2021-11-17 |
国立研究開発法人理化学研究所 |
非天然アミノ酸導入抗体
|
|
EP3394098A4
(en)
|
2015-12-25 |
2019-11-13 |
Chugai Seiyaku Kabushiki Kaisha |
ANTI-MYOSTATIN ANTIBODIES AND METHOD OF USE
|
|
CN106924754B
(zh)
*
|
2015-12-30 |
2021-11-09 |
北京大学 |
聚氨基酸偶联物
|
|
AU2017212739B2
(en)
|
2016-01-27 |
2024-03-21 |
Sutro Biopharma, Inc. |
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
|
|
CN116271014A
(zh)
|
2016-08-05 |
2023-06-23 |
中外制药株式会社 |
用于预防或治疗il-8相关疾病的组合物
|
|
IL315727A
(en)
*
|
2016-12-23 |
2024-11-01 |
Visterra Inc |
Binding polypeptides and methods for their preparation
|
|
KR102755136B1
(ko)
*
|
2017-05-09 |
2025-01-17 |
심리스 바이오로직스 게엠베하 |
변형된 마이크로시스틴 및 노둘라린
|
|
KR20200086678A
(ko)
*
|
2017-10-13 |
2020-07-17 |
어슈어, 인크. |
뉴클레오시드 리버스 트랜스크립타제 억제제 요법에 대한 준수를 모니터링하기 위한 생성물 및 방법
|
|
CN110283249A
(zh)
*
|
2018-03-19 |
2019-09-27 |
江苏莱博德医疗科技有限公司 |
一种抗白介素6的人ScFv单链抗体
|
|
US20190292310A1
(en)
*
|
2018-03-20 |
2019-09-26 |
Northeastern University |
Synthesis of high density molecular dna brushes via organic-phase ring-opening metathesis (co)polymerization
|
|
SG11202010025YA
(en)
|
2018-05-31 |
2020-11-27 |
Glyconex Inc |
Therapeutic antibodies binding to biantennary lewis b and lewis y antigens
|
|
MX2021003976A
(es)
|
2018-10-11 |
2021-05-27 |
Amgen Inc |
Procesamiento posterior de constructos de anticuerpos biespecificos.
|
|
CN114375205A
(zh)
|
2019-06-20 |
2022-04-19 |
武田药品工业株式会社 |
用基于病毒的基因疗法进行治疗的方法
|
|
TW202535466A
(zh)
|
2019-09-09 |
2025-09-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-il-23p19抗體調配物
|
|
US20230192824A1
(en)
*
|
2020-04-02 |
2023-06-22 |
United States Of America As Represented By The Secretary Of The Navy |
Antigen Binding Proteins to Class 5 ETEC Adhesins
|
|
CN113203863B
(zh)
*
|
2021-04-28 |
2022-01-21 |
北京美联泰科生物技术有限公司 |
一种适用于白介素-6检测的缓冲液
|
|
CN113150122B
(zh)
*
|
2021-05-19 |
2023-03-17 |
上海儒克生物科技有限公司 |
高通量全兔源单克隆抗体的制备方法
|
|
KR20240035758A
(ko)
|
2021-05-24 |
2024-03-18 |
비르 바이오테크놀로지, 인코포레이티드 |
조작된 폴리펩타이드
|
|
CN115957319B
(zh)
*
|
2022-10-14 |
2023-06-30 |
北京东方百泰生物科技股份有限公司 |
一种抗nkg2a单克隆抗体的注射制剂
|
|
WO2025010424A1
(en)
|
2023-07-06 |
2025-01-09 |
Vir Biotechnology, Inc. |
Antibodies against staphylococcus antigens and methods of using the same
|
|
PL448731A1
(pl)
*
|
2024-05-31 |
2025-12-01 |
Celon Pharma Spółka Akcyjna |
Przeciwciała bispecyficzne anty–IL-17A i anty-IL-6 oraz ich zastosowanie w terapii, zwłaszcza w leczeniu chorób immunologicznych
|
|
CN119023961B
(zh)
*
|
2024-08-27 |
2026-02-03 |
首都医科大学附属北京朝阳医院 |
用于检测干眼病生物标志物的试剂及其制备方法和用途
|
|
WO2026102136A1
(en)
|
2024-11-07 |
2026-05-15 |
Glyconex Inc. |
Anti-lewis y antibody and pro-antibody thereof
|
|
CN120329434B
(zh)
*
|
2025-06-23 |
2025-10-21 |
杭州市第一人民医院(西湖大学附属杭州市第一人民医院) |
一种mfge8单克隆抗体及其制备方法和应用
|